Alyssa M Hohmann, OCCUPATIONAL THERAPI Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 170 Argyle Street, Sandusky, MI 48471 Phone: 810-648-0210 Fax: 810-648-0214 |
Gwen Vermeersch, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 217 E Sanilac Rd, Sandusky, MI 48471 Phone: 810-648-0330 |
Mary Jane Gueldenzopf, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 227 E Sanilac Rd, Sandusky, MI 48471 Phone: 810-648-0330 |
Tanya Trend-wilson, MOT, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 190 Delaware St, Sandusky, MI 48471 Phone: 810-583-0334 |
Toby Betts Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 227 E Sanilac Rd, Sandusky, MI 48471 Phone: 810-648-0330 |
Brandean Tilley Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 227 E Sanilac Rd, Sandusky, MI 48471 Phone: 810-648-0330 |
Debra Ann Fagan Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 137 N Elk St, Sandusky, MI 48471 Phone: 810-648-3017 |
News Archive
The American Association of Critical-Care Nurses (AACN) invites nurses and other healthcare professionals who care for high acuity and critically ill patients and their families to its 2013 National Teaching Institute & Critical Care Exposition (NTI) in Boston May 20-23, with preconferences May 18-19.
The American College of Physicians has found strong evidence that routine imaging for low back pain with X-ray or advanced imaging methods such as CT scan or MRI does not improve the health of patients.
A team of scientists from the National Institutes of Health (NIH), USA, has recently identified six novel small molecule inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants. The study is currently available on the bioRxiv* preprint server.
A scientist at Leeds whose research is challenging conventional thinking on how the cholesterol-reducing drugs statins benefit cardiac patients, has secured funding to further investigate her findings.
Vivakor™, Inc. (OTCBB: VIVK) today announced the results of independent, third-party validation testing of its VivaBlend™ nutraceutical product. VivaBlend is a powerful extract developed by the scientists at Vivakor and is derived from over 18 highly bioactive fruits, vegetables and legumes. Through a proprietary formulation and extraction process, Vivakor scientists have maximized the health benefits of VivaBlend by creating an optimum blend of super-antioxidants and powerful plant phenolics and flavonoids.
› Verified 6 days ago